Biological Products, (No Diagnostic Substances) · DE · CIK 1826457
Develops molecular glue degraders to selectively destroy disease-causing proteins using AI and proprietary tools
Comparable business profile · signals at a glance
In the 90 days to Mar 4, 2026: 6 sold $1.2M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 4, 2026 | Dunn EdmundPrincipal Accounting Officer | Sell | 139 | $17.96 | $2K |
| Mar 2, 2026 | Warmuth MarkusPresident & CEO | Sell | 5,466 | $17.92 | $98K |
| Mar 2, 2026 | Dunn EdmundPrincipal Accounting Officer | Sell | 536 | $17.50 | $9K |
| Feb 27, 2026 | Dunn EdmundPrincipal Accounting Officer | Sell | 25,164 | $18.10 | $455K |
| Feb 23, 2026 | Janku FilipChief Medical Officer | Sell | 9,189 | $19.50 | $179K |
| Jan 7, 2026 | Warmuth MarkusPresident & CEO | Sell | 3,707 | $23.24 | $86K |
| Jan 7, 2026 | Warmuth MarkusPresident & CEO | Sell | 1,450 | $23.88 | $35K |
| Jan 7, 2026 | Warmuth MarkusPresident & CEO | Sell | 309 | $24.57 | $8K |
| Jan 5, 2026 | Warmuth MarkusPresident & CEO | Sell | 10,135 | $15.17 | $154K |
| Jan 5, 2026 | Townson SharonChief Scientific Officer | Sell | 3,155 | $15.17 | $48K |
| Jan 5, 2026 | Nickson PhilipChief Business & Legal Officer | Sell | 3,155 | $15.17 | $48K |
| Jan 5, 2026 | Janku FilipChief Medical Officer | Sell | 3,155 | $15.17 | $48K |
| Jan 5, 2026 | Champoux JenniferChief Operating Officer | Sell | 2,629 | $15.17 | $40K |
| Jan 5, 2026 | Dunn EdmundPrincipal Accounting Officer | Sell | 1,039 | $15.17 | $16K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.